98%
921
2 minutes
20
Background: Several options for the treatment of ingrowing toenails are available, ranging from simple conservative approaches to extensive surgical procedures.
Objective: To evaluate in a long-term follow-up (36 months) the efficacy of chemical matricectomy with phenol for the treatment of ingrowing toenails.
Methods And Materials: A total of 197 phenol ablations were performed in 139 patients with stage 2 and 3 disease. Each patient was examined weekly until full wound healing was achieved and was followed for 36 months to assess the long-term efficacy of the treatment. The healing period after surgery ranged from 2 to 4 weeks; few postoperative complications were seen.
Results: Only three recurrences were observed (after 2, 4, and 11 months). Short-term results were excellent. No severe complications occurred during the 36-month follow-up period. Cosmetic results were remarkable. The success rate was 98.5%.
Conclusions: Phenol cauterization is an excellent surgical method for the treatment of ingrowing toenails, being simple and associated with low morbidity and a high success rate, even over the long term (36 months).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1524-4725.2010.01624.x | DOI Listing |
J Cosmet Dermatol
September 2025
Department of Practical Cosmetology and Skin Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Poland.
Background: Ingrown toenails are a disease that often begins in childhood. It occurs as the penetration of the nail plate into the surrounding tissue as a result of various factors. Patients often report to various specialists, including podiatrists and dermatologists, at an advanced stage of this disease.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Guizhou Nursing Vocational College, Guiyang, China.
The purpose of this study was to evaluate the adverse events (AEs) associated with tucatinib by mining data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) and explore potential drug-related AEs, thereby guiding safe clinical use.
View Article and Find Full Text PDFArch Dermatol Res
November 2024
Dermatology and Venereology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Ingrown toenails (IGTN) are a prevalent, debilitating nail disorder that occurs when the edge of the nail plate grows abnormally to penetrate the periungual dermis. Multiple risk factors have been identified in the etiology. In this study, we aimed to investigate the risk factors that predispose patients to IGTN.
View Article and Find Full Text PDFCell Transplant
October 2024
Harvard Medical School, Joslin Diabetes Center, Boston, MA, USA.
Human islets can be transplanted into the portal vein for T1 diabetes, and a similar procedure is being used in a clinical trial for stem cell-derived beta-like cells. Efforts have been underway to find an alternative transplant site that will foster better islet cell survival and function. Although conceptually attractive, the subcutaneous (SC) site has yielded disappointing results, in spite of some improvements resulting from more attention paid to vascularization and differentiation factors, including collagen.
View Article and Find Full Text PDFHealth Technol Assess
July 2024
School of Health and Related Research, Regent Court, Sheffield, UK.
Background: There is no consensus on optimal management of pilonidal disease. Surgical practice is varied, and existing literature is mainly single-centre cohort studies of varied disease severity, interventions and outcome assessments.
Objectives: A prospective cohort study to determine: • disease severity and intervention relationship • most valued outcomes and treatment preference by patients • recommendations for policy and future research.